---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-315032"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:36:19.719514+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sarepta exchanges $291M of 1.25% notes due 2027 for 4.875% notes due 2030 plus $31.6M cash

## Summary
- Exchanges $291.4M principal of 1.25% convertibles due 2027 for same principal of 4.875% convertibles due 2030, plus $31.6M in cash.
- New 4.875% notes are part of same series as $602M issued Aug 2025; post-exchange total $893.4M outstanding.
- Approximately $158.6M of existing 1.25% notes will remain outstanding with unchanged terms.
- Placement agent intends to buy ~691,000 SRPT shares in private transactions from exchanging investors at a discount.
- Exchange expected to close on or about December 18, 2025, subject to customary closing conditions.

## SEC filing metadata
- accession: 0001193125-25-315032
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312525315032/0001193125-25-315032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312525315032/d55628d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-315032
- JSON: https://secwatch.observer/filing/0001193125-25-315032.json
- Plain text: https://secwatch.observer/filing/0001193125-25-315032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.